Maddy summarySRES 593 is a Senate resolution honoring former U.S. Senator Kaneaster Hodges, Jr. of Arkansas, who served from 1977 to 1978. The resolution expresses the Senate’s "profound sorrow" at his death and directs the Secretary of the Senate to transmit an enrolled copy to his family. It also calls for the Senate to adjourn as a mark of respect. This is a ceremonial resolution with no policy provisions or direct impact on legislation or constituents.
Sponsored bills
This resolution recognizes that Black women are experiencing high, disproportionate rates of maternal mortality and morbidity in the United States and that Black Maternal Health Week is an opportunity to deepen the national conversation about Black maternal health.
Get the Lead Out of Assisted Housing Act of 2022 This bill addresses the removal of lead from drinking water in federally assisted housing. Specifically, the bill requires the Department of Housing and Urban Development (HUD) to require specified testing and remediation with respect to water service lines containing lead; authorizes HUD to inspect all sources of lead contamination in federally assisted housing and to mitigate sources of lead exposure; establishes a grant program for states and local governments to create inventories of water service lines containing lead and to test for lead in the drinking water at child care facilities, schools, and public water fountains; and allows recipients of certain HUD assistance to use such assistance to replace water fixtures and service lines containing lead.
Discounted Drugs for Clinical Trials Act This bill allows researchers to obtain certain high-cost drugs and biologics at discounted prices from manufacturers. Researchers must apply to the Food and Drug Administration for approval; manufacturers must sell the approved quantity of drugs to researchers at the discounted price and are subject to civil actions from researchers for noncompliance.
Discounted Drugs for Clinical Trials Act This bill allows researchers to obtain certain high-cost drugs and biologics at discounted prices from manufacturers. Researchers must apply to the Food and Drug Administration for approval; manufacturers must sell the approved quantity of drugs to researchers at the discounted price and are subject to civil actions from researchers for noncompliance.
Pharmaceutical Research Transparency Act of 2022 This bill requires the disclosure of costs associated with clinical trials and pharmaceutical research and development. Specifically, the National Institutes of Health must create a publicly available repository of cost data from certain clinical trials that test the efficacy of drugs, biological products, and devices in human subjects. For each applicable trial, the registry must, among other information, include the total and per patient cost of the trial, as well as costs for personnel, health care services, and other categories of expenditures. Information must be added to the registry within one year of the trial's completion. The bill also requires drug manufacturers to include their research and development expenditures for drugs and biological products in annual disclosures made to the Securities and Exchange Commission.
This resolution designates April 16 through April 24, 2022, as National Park Week. The resolution also encourages the people of the United States and the world to responsibly visit, experience, recreate in, and support the treasured national parks of the United States.
Maddy summarySenate Resolution 577 designates April 2022 as "Parkinson's Awareness Month" to raise public awareness about Parkinson's disease. The resolution highlights the disease's impact on over 1 million Americans, its status as the 14th leading cause of death, and the need for continued research and community support. It does not create new laws or funding but symbolically supports efforts to improve quality of life for those living with Parkinson's and their caregivers.
Rural Hospital Support Act This bill modifies and extends certain payment adjustments for rural hospitals under Medicare's inpatient prospective payment system. Specifically, the bill indexes payment adjustments for sole community hospitals and Medicare-dependent hospitals to FY2016 operating costs, if it results in higher payments for such hospitals. The bill also makes payment adjustments for Medicare-dependent hospitals and low-volume hospitals permanent (the adjustments currently expire at the end of FY2022).
Targeting Resources for Equitable Access to Treatment for Long COVID Act or the TREAT Long COVID Act This bill requires the Department of Health and Human Services to award competitive grants to create or expand the capacity of clinics that treat patients with persistent, long-term symptoms following recovery from acute COVID-19 (i.e., Long COVID). Eligible recipients include federally qualified health centers, rural health clinics, urban Indian health centers, and state and local health departments.